NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
Pfizer
Replimune Inc.
Avenzo Therapeutics, Inc.
Auricula Biosciences Inc.
DualityBio Inc.
Inhibrx Biosciences, Inc
Tanabe Pharma America, Inc.
CRISPR Therapeutics
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Numab Therapeutics AG
HiberCell, Inc.
Intensity Therapeutics, Inc.
Vaccinex Inc.
Iovance Biotherapeutics, Inc.
Simcha IL-18, Inc.
Atara Biotherapeutics
BeiGene
Elucida Oncology
Kyowa Kirin Co., Ltd.
Evopoint Biosciences Inc.
CARsgen Therapeutics Co., Ltd.
Bristol-Myers Squibb
MedImmune LLC
NBE-Therapeutics AG
Kineta Inc.
Genelux Corporation
Vaccinex Inc.
Genocea Biosciences, Inc.
Rexahn Pharmaceuticals, Inc.
Eisai Inc.
Sinocelltech Ltd.
Generic Devices Consulting, Inc.
Hanmi Pharmaceutical Company Limited
AVEO Pharmaceuticals, Inc.
Ligand Pharmaceuticals
Pfizer
Aegera Therapeutics